Arch Therapeutics, Inc. Share Price Other OTC
Equities
ARTH
US03939W1099
Medical Equipment, Supplies & Distribution
Sales 2022 | 0.02 1.3 | Sales 2023 | 0.08 6.3 | Capitalization | 6.1M 508M |
---|---|---|---|---|---|
Net income 2022 | -5M -416M | Net income 2023 | -6M -500M | EV / Sales 2022 | 47,34,69,716 x |
Net Debt 2022 | 2.62M 218M | Net Debt 2023 | 5.41M 450M | EV / Sales 2023 | 15,18,85,320 x |
P/E ratio 2022 |
-0.87
x | P/E ratio 2023 |
-0.57
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 73.18% |
Managers | Title | Age | Since |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 16/09/16 |
Michael Abrams
DFI | Director of Finance/CFO | 55 | 10/21/10 |
Shawn Carlson
SAM | Sales & Marketing | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 16/09/16 |
Fish Guy
BRD | Director/Board Member | 64 | 31/21/31 |
Laurence Hicks
BRD | Director/Board Member | - | 27/21/27 |
1st Jan change | Capi. | |
---|---|---|
-5.10% | 11.34B | |
+4.02% | 9.11B | |
+38.12% | 5.53B | |
-23.70% | 4.61B | |
+8.55% | 3.45B | |
-6.44% | 2.87B | |
-5.85% | 2.1B | |
-11.84% | 2.08B | |
-23.36% | 1.78B |